- Home
- Análise grátis de aplicativos
- 4AT clinical test for delirium
- 4AT clinical test for delirium Vs. ONCOassist
4AT clinical test for delirium vs ONCOassist Uso e estatísticas
The 4AT is a simple and short (less than 2 min) delirium detection tool designed for easy and effective clinical use. It does not require special training.
The 4AT is the best validated delirium tool in the literature. There are more than 25 diagnostic test accuracy studies involving more than 5000 patients. It is highly sensitive and specific.
The 4AT is now one of the most commonly-used tools in practice globally.
It is proven in routine care, with high completion rates and delirium detection at expected clinical rates.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
Please note: This application, as a decision-support aid, is to be used by a practicing healthcare professional(“HCP”) and does not replace clinical judgement. It is not designed for use by patients and does not replace the advice of a doctor.
ONCOassist is a comprehensive suite of decision support tools developed by oncology professionals, for oncology professionals. It includes a range of breakthrough tools designed to manage patient care effectively. Let's take a closer look at some of the features available:
• NCCN Treatment Protocols: Developed in collaboration with the NCCN, this tool provides information on regimens taken from the NCCN template database.
• Adjuvant Tools: These tools offer 5 and 10-year overall survival rates for patients with and without chemotherapy in an adjuvant setting. Breast cancer, colon cancer, and GIST tools are among the many adjuvant decision support tools available.
• Useful formulas: Body Surface Area, Chemotherapy Dose Calculator, QTc, ECOG Performance Score, Khorana Score, MASCC Risk Index, and many more are included. These calculators simplify medical calculations and include frequently needed conversions and dosage calculations.
• Common Toxicity Criteria for Adverse Events (CTCAE v4.0 & 5.0): This tool provides a standardized classification of adverse effects of drugs used in cancer therapy. CTCAE versions 5.0 and 4.0 are available in an easy-to-use and interactive format.
• AJCC TNM staging: The tool provides criteria for every malignancy and includes the AJCC 7th, 8th, and 9th edition staging criteria.
• Prognostic Scores: This tool offers over 17 prognostic scores for a range of specialties. It helps with prognostication, risk stratification, and determining eligibility for specific treatments or clinical trials.
• Drug info section: Over 200 oncology drugs are available in an easy-to-use and interactive format.
• Drug interaction checker: This tool helps users quickly check for potential drug interactions.
• IO toxicity management tool: This tool is designed to manage immune-related adverse events.
• ONCOnews: From breaking news to in-depth analysis, ONCOnews brings together all oncology news sources in one place.
• ONCOvideos: This offers access to the most recent videos from Oncology Spotlight, which provides insights into the experiences of oncology professionals. Additionally, users can watch OncoAlert and Oncology Brother videos.
ONCOassist offers oncology professionals the following benefits:
Saves Time
Oncology professionals no longer waste time searching through the internet for safe validated information to aid them with their decision making, all of the tools and information they need is available within ONCOassist and is available without the need for internet access.
Improves quality of care
ONCOassist promotes the use of evidence-based medicine. It is also the only CE approved oncology app on the market.
Helps Empower Patients
Adjuvant decision support tools contain patient-friendly information to allow for a more collaborative decision-making process.
Regularly updating
ONCOassist will be updated regularly with new prognostic tools and calculators. We will listen to your feedback and update accordingly. Email us at any time using feedback@oncoassist.com.
ONCOassist is regulated by the Irish Health Products Regulatory Authority and is CE marked for conformance as a medical device.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
4AT clinical test for delirium versus ONCOassist comparação de classificação
Compare a tendência de classificação de 4AT clinical test for delirium nos últimos 28 dias versus ONCOassist
Classificação
Nenhum dado disponível
Comparação da classificação de 4AT clinical test for delirium vs. ONCOassist por país
Compare a tendência de classificação de 4AT clinical test for delirium nos últimos 28 dias versus ONCOassist
Todas as categorias
Nenhum dado disponível
Médico
Faça comparações com qualquer site com o nosso teste grátis
janeiro 9, 2026